We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$221M
AUM Growth
+$8.65M
Cap. Flow
-$6.33M
Cap. Flow %
-2.87%
Top 10 Hldgs %
71.57%
Holding
93
New
9
Increased
15
Reduced
13
Closed
8

Top Buys

Rank Stock Value
1
BBIO icon
BridgeBio Pharma
BBIO
+$2.91M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
+$2.47M
3
LENZ
LENZ Therapeutics
LENZ
+$2.23M
4
ALKS icon
Alkermes
ALKS
+$1.46M
5
LQDA icon
Liquidia Corp
LQDA
+$1.33M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.2M
2
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$2.85M
3
VRNA
Verona Pharma
VRNA
+$2.44M
4
ARDX icon
Ardelyx
ARDX
+$2.42M
5
OABI icon
OmniAb
OABI
+$2.36M

Sector Composition

Rank Sector Weight
1 Healthcare 31.49%
2 Materials 24.07%
3 Financials 19.36%
4 Communication Services 9.05%
5 Industrials 1.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERA icon
51
Vera Therapeutics
VERA
$2.54B
$471K 0.21%
20,000
+10,000
+100% +$225K
XENE icon
52
Xenon Pharmaceuticals
XENE
$6.32B
$343K 0.16%
10,962
-4,904
-31% -$160K
OBIO icon
53
Orchestra BioMed
OBIO
$224M
$268K 0.12%
+100,000
New +$292K
WVE icon
54
Wave Life Sciences
WVE
$1.12B
$260K 0.12%
40,000
+30,000
+300% +$198K
ATYR
55
aTyr Pharma
ATYR
$46.4M
$255K 0.12%
50,367
-173,040
-77% -$681K
IBB icon
56
iShares Biotechnology ETF
IBB
$9.31B
$253K 0.11%
+2,000
New +$246K
XBI icon
57
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$249K 0.11%
3,000
-10,643
-78% -$849K
LLY icon
58
Eli Lilly
LLY
$1.07T
$234K 0.11%
300
– –
DAWN
59
DELISTED
Day One Biopharmaceuticals
DAWN
$219K 0.1%
+33,714
New +$232K
NVDA icon
60
NVIDIA
NVDA
$5.01T
$202K 0.09%
1,280
– –
AVGO icon
61
Broadcom
AVGO
$1.82T
$196K 0.09%
710
– –
KO icon
62
Coca-Cola
KO
$354B
$142K 0.06%
2,000
– –
IWP icon
63
iShares Russell Mid-Cap Growth ETF
IWP
$20B
$96.4K 0.04%
695
– –
LEGH icon
64
Legacy Housing
LEGH
$630M
$90.6K 0.04%
4,000
-2,500
-38% -$58.5K
EBC icon
65
Eastern Bankshares
EBC
$5.25B
$76.3K 0.03%
5,000
– –
TTE icon
66
TotalEnergies
TTE
$193B
$73.7K 0.03%
1,200
– –
PWR icon
67
Quanta Services
PWR
$93.9B
$66.5K 0.03%
176
– –
AMZN icon
68
Amazon
AMZN
$2.5T
$65.8K 0.03%
300
– –
FSK icon
69
FS KKR Capital
FSK
$2.98B
$59.7K 0.03%
2,875
– –
URI icon
70
United Rentals
URI
$71.1B
$58.8K 0.03%
78
– –
FSBW icon
71
FS Bancorp
FSBW
$324M
$57.5K 0.03%
1,460
– –
GOOGL icon
72
Alphabet (Google) Class A
GOOGL
$3.91T
$52.9K 0.02%
300
– –
BRSL
73
Brightstar Lottery PLC
BRSL
$1.91B
$39.5K 0.02%
2,500
– –
DHR icon
74
Danaher
DHR
$135B
$35.6K 0.02%
180
– –
DOW icon
75
Dow Inc
DOW
$21.6B
$31.9K 0.01%
1,206
– –
1 2
3
4

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q2 2025 Portfolio in Review

As of Q2 2025, David M. Knott Jr held 93 positions worth $221M, up 4.1% from $212M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

David M. Knott Jr's Q2 2025 filing shows 9 new, 15 increased, 13 reduced and 8 closed positions. Its largest new stake was BridgeBio Pharma: 80,000 shares worth $3.45M. The largest sale was Pfizer, an estimated $4.2M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Materials and Financials.

  • David M. Knott Jr's largest Q2 2025 buy was BridgeBio Pharma: 80,000 shares worth $3.45M.
  • David M. Knott Jr added most to Syndax Pharmaceuticals in Q2 2025, an estimated $2.47M increase.
  • David M. Knott Jr's biggest Q2 2025 reduction was Pfizer, cutting an estimated $4.2M.
  • David M. Knott Jr fully exited Ardelyx in Q2 2025, selling an estimated $2.42M.
  • David M. Knott Jr's ten largest holdings make up 72% of its $221M portfolio in Q2 2025.
  • David M. Knott Jr opened 9 new positions and closed 8 in Q2 2025.
  • David M. Knott Jr's portfolio value rose 4.1% quarter-over-quarter to $221M.

Based on David M. Knott Jr's 13F filing for Q2 2025, filed 11 Aug 2025.